Diabetic Footwear Market Report 2026

Diabetic Footwear Market Overview

• Diabetic Footwear market size has reached to $9.2 billion in 2025 • Expected to grow to $14.74 billion in 2030 at a compound annual growth rate (CAGR) of 9.8% • Growth Driver: Rising Diabetic Population Fuels Growth In The Diabetic Footwear Market • Market Trend: Technological Innovations Revolutionizing The Diabetic Footwear Market • North America was the largest region in 2025.

What Is Covered Under Diabetic Footwear Market?

Diabetic footwear refers to therapeutic footwear that is broader and deeper than conventional shoes and made of special protective inserts and soft materials. It includes a larger toe box to avoid squeezing the toes and reduce the possibility of bottom blisters (ulcers) produced by disunion and pressure. The diabetic footwear is used to relieve pressure and calluses on the bottom of the foot. The main types of diabetic footwear are shoes, sandals, and slippers. The diabetic shoes are made of special protective inserts and soft materials and are used for increasing blood circulation and nerve sensation, having a wide toe box, and massaging to reduce pressure. The various distribution channels include online platforms, specialty stores, footwear stores, and others and are used by various end-users, including men, women.

What Is The Diabetic Footwear Market Growth Forecast?

The diabetic footwear market size is expected to see strong growth in the next few years. It will grow to $14.74 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to growing demand for customized orthopedic footwear, rising adoption of smart insole technologies, expansion of online distribution channels, increasing focus on preventive diabetic care, product innovation for enhanced comfort and mobility. Major trends in the forecast period include increasing demand for therapeutic footwear designs, growing use of pressure-relief insoles, expansion of customized diabetic footwear solutions, rising adoption of lightweight and breathable materials, enhanced focus on foot ulcer prevention.

Global Diabetic Footwear Market Segmentation

1) By Type: Shoes, Sandals, Slippers 2) By Distribution Channel: Online Platform, Specialty Stores, Footwear Stores, Other Distribution Channels 3) By End User: Men, Women Subsegments: 1) By Shoes: Athletic Shoes, Dress Shoes, Casual Shoes, Therapeutic Shoes 2) By Sandals: Open-Toe Sandals, Closed-Toe Sandals, Adjustable Sandals 3) By Slippers: Indoor Slippers, Outdoor Slippers, Heated Slippers

What Is The Driver Of The Diabetic Footwear Market?

The increase in the number of diabetic patients will propel the growth of the diabetic footwear market going forward. Diabetes is a chronic health condition that results in high blood glucose levels. Diabetic footwear can help prevent serious foot health complications that can arise as a result of diabetes and also provide the necessary benefits, such as increased blood circulation, a wide toe box, and massaging to reduce pressure in the areas of the foot that are most susceptible to pain. For instance, in June 2023, according to the report published by the Institute for Health Metrics and Evaluation, a US-based independent population health research organization, there will be more than double, or 1.3 billion, diabetic people in the next 30 years. Also, by 2050, the overall number of diabetics is expected to reach 529 million. Therefore, the increasing number of diabetic patients is driving the growth of the diabetic footwear industry.

Key Players In The Global Diabetic Footwear Market

Major companies operating in the diabetic footwear market are Podartis Srl Co., Orthofeet Inc., Dr. Comfort LLC, Drew Shoe Corp., Aetrex Worldwide Inc., Finn Comfort USA Inc., Apex Foot Health Industries LLC, Propét USA Inc., Anodyne Shoes LLC, P.W. Minor and Son Inc., Pedorthic Shoe Company, San Antonio Shoe Inc., DARCO International Inc., Diabetic Soles Inc., Orthopedic Footwear LLC, SureFit Footwear Inc., Ewidex Footwear Inc., Gravity Defyer Medical Footwear Inc., Orthoshoes Inc., Doctor Cutillas Footwear SL

Global Diabetic Footwear Market Trends and Insights

Major companies operating in the diabetic footwear market are focused on developing innovative products such as smart shoes to enhance patient care and improve health outcomes. These smart shoes often incorporate advanced features like pressure sensors and monitoring systems that help detect foot issues early, thereby reducing the risk of complications such as ulcers and amputations. For instance, in March 2024, nine students of Oman College of Health Sciences, an Oman-based educational institution, developed a smart shoe with the aim of reducing complications in diabetic patients. This innovative footwear aims to address critical health issues associated with diabetes, particularly diabetic foot complications, which can lead to severe consequences like foot ulcers and amputations.

What Are Latest Mergers And Acquisitions In The Diabetic Footwear Market?

In August 2025, DiabeticShoe, an India-based provider of diabetic and orthopedic footwear, partnered with Carbon Meditek to expand access to therapeutic and diabetic footwear products. Through this collaboration, the companies aim to enhance the availability of clinically designed footwear for diabetic patients and individuals requiring orthopedic support. This partnership underscores the diabetic and orthopedic footwear market’s growing emphasis on accessibility, customized solutions, and patient-focused product distribution. Carbon Meditek is an India-based provider of custom orthotic footwear, diabetic socks, and orthopedic supports.

Regional Outlook

North America was the largest region in the diabetic footwear market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Diabetic Footwear Market?

The diabetic footwear market consists of sales of in-depth shoes, healing shoes, and custom-made shoes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.